Company news
Hims & Hers Health, Inc. (NYSE:HIMS) news
Every Hims & Hers Health, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)
August 12, 2026
Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results
August 10, 2026
Hims & Hers Responds to FTC Lawsuit
July 29, 2026
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
July 17, 2026
Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
July 13, 2026
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
June 4, 2026
Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians
June 3, 2026
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
June 2, 2026
Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market
June 2, 2026
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
May 28, 2026
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
May 21, 2026
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate ...
May 18, 2026
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven...
May 18, 2026
Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
May 11, 2026
Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
April 28, 2026
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
April 13, 2026
Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year
March 31, 2026
Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
March 26, 2026
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
March 10, 2026
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
March 10, 2026
Hims & Hers Announces Strategic Shift for US Weight Loss Business
March 9, 2026
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
February 19, 2026
Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehea...
February 5, 2026
Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*
February 5, 2026
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care
February 4, 2026
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
February 2, 2026
Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over
January 29, 2026
Cold Spring Harbor Laboratory Appoints Jack Abraham and Terri Keogh to Board of Trustees
January 28, 2026
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK
December 10, 2025
Hims & Hers Now Serving Customers in Canada
December 4, 2025
Hims & Hers Continues Major International Expansion With Official Entry Into Canada
December 4, 2025
Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology
December 3, 2025
Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization
November 17, 2025
Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy
November 17, 2025
Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys
November 13, 2025
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
November 3, 2025
Liberate Earns Spot on Redpoint's Prestigious AI64 List of Top Emerging Enterprise AI Companies
October 27, 2025
Maxima Named to Redpoint’s AI64: Celebrating the Top Emerging Enterprise AI Applications
October 23, 2025
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
October 20, 2025
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026
October 15, 2025
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025
October 13, 2025
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office
October 9, 2025
Roundhill Launches Meme Stock ETF (MEME)
October 8, 2025
Leverage Shares Launches First 3x Single-Stock ETPs on HOOD, HIMS, UNH and Others
September 16, 2025
Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments
September 10, 2025
MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Hospital Information System Quadrant Report 2025
August 8, 2025
Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results
August 4, 2025
Faire Appoints Former DoorDash COO Christopher Payne to Board of Directors
July 29, 2025
Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care
July 29, 2025